June 11, 2014 — Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce new clinical data supporting the positive safety profile of NX-1207, the Company’s lead compound in late Phase 3 testing for prostate enlargement (BPH or benign prostate hyperplasia). Recent pharmacokinetic studies using a newly developed highly sensitive blood test for NX-1207 have shown that the drug is undetectable in the blood post-injection, providing strong evidence that the drug, once injected into the prostate, remains confined to the prostate and thus unable to affect other organs such as the liver, kidneys, heart, or testes. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) weekly performance is -0.99%. On last trading day company shares ended up $5.00. Analysts mean target price for the company is $19.56. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) distance from 50-day simple moving average (SMA50) is -3.92%.
On June 5, SurModics IVD, Inc., a wholly owned subsidiary of SurModics, Inc. (NASDAQ:SRDX) and a market leader forin vitro diagnostic assay components, announced the launch of BioFX® Liquid Nova-Stop Solution, a non-corrosive, non-hazardous stop solution for TMB microwell substrates. SurModics, Inc. (NASDAQ:SRDX) shares fell -0.66% in last trading session and ended the day on $20.92. Gross Margin is 58.50% and its return on assets is 13.10%. SurModics, Inc. (NASDAQ:SRDX) quarterly performance is -11.80%.
On June 4, 2014, Chembio Diagnostics Inc (NASDAQ:CEMI) issued a press release entitled “Chembio Launches U.S. Sales and Marketing Initiative”. Chembio Diagnostics Inc (NASDAQ:CEMI) shares moved down -1.51% in last trading session and was closed at $3.26, while trading in range of $3.26 – $3.31. Chembio Diagnostics Inc (NASDAQ:CEMI) year to date (YTD) performance is -3.26%.
June 3, 2014 — Tuesday Morning Corporation (NASDAQ:TUES) a leading closeout retailer with 811 stores across the United States as of May 8, 2014, specializing in selling deeply discounted, upscale decorative home accessories, housewares, seasonal goods and famous-maker gifts, announced that Susan H. Davidson has joined the Company as SVP, Marketing. She succeeds Ross Manning in this capacity, who has left the Company and is pursuing other professional opportunities. Tuesday Morning Corporation (NASDAQ:TUES) ended the last trading day at $18.22. Company weekly volatility is calculated as 4.11% and price to cash ratio as 19.04. Tuesday Morning Corporation (NASDAQ:TUES) showed a negative weekly performance of -1.57%.
On June13, Dollar Tree Inc (NASDAQ:DLTR)‘s stock had its “neutral” rating restated by Zacks in a research note issued to investors on Friday. They currently have a $57.00 price objective on the stock. Zacks‘s price target suggests a potential upside of 5.69% from the company’s current price. Dollar Tree, Inc. (NASDAQ:DLTR) net profit margin is 7.50% and weekly performance is -2.21%. On last trading day company shares ended up $ 53.92. Analysts mean target price for the company is $61.79. Dollar Tree, Inc. (NASDAQ:DLTR) distance from 50-day simple moving average (SMA50) is 3.14%.